Get started
BIOXYNE LIMITEDBIOXYNE LIMITEDBIOXYNE LIMITED

BIOXYNE LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BXN chart


Full chart

Key stats


Market capitalization
‪51.96 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
21.818
Basic EPS (TTM)
0.001 AUD
Net income (FY)
‪−13.29 M‬ AUD
Revenue (FY)
‪9.33 M‬ AUD
Shares float
‪2.12 B‬
Beta (1Y)
1.78

About BIOXYNE LIMITED


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Sam Watson
Website
bioxyne.com
Headquarters
Sydney
Founded
1998
ISIN
AU000000BXN6
FIGI
BBG000DLY723
Bioxyne Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BXN news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as BXN.

Frequently Asked Questions


The current price of BXN is 0.024 AUD — it hasn't changed in the past 24 hours. Watch BIOXYNE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BIOXYNE LIMITED stocks are traded under the ticker BXN.
BXN stock has fallen by −4.00% compared to the previous week, the month change is a −17.24% fall, over the last year BIOXYNE LIMITED has showed a 242.86% increase.
BXN reached its all-time high on May 3, 2012 with the price of 0.203 AUD, and its all-time low was 0.002 AUD and was reached on Jun 24, 2013. View more price dynamics on BXN chart.
See other stocks reaching their highest and lowest prices.
BXN stock is 4.17% volatile and has beta coefficient of 1.78. Track BIOXYNE LIMITED stock price on the chart and check out the list of the most volatile stocks — is BIOXYNE LIMITED there?
Today BIOXYNE LIMITED has the market capitalization of ‪51.96 M‬, it has increased by 4.17% over the last week.
Yes, you can track BIOXYNE LIMITED financials in yearly and quarterly reports right on TradingView.
BXN net income for the last half-year is ‪3.28 M‬ AUD, while the previous report showed ‪−1.00 M‬ AUD of net income which accounts for 426.17% change. Track more BIOXYNE LIMITED financial stats to get the full picture.
No, BXN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BXN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOXYNE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOXYNE LIMITED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOXYNE LIMITED stock shows the buy signal. See more of BIOXYNE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.